Multidisciplinary Therapy of Pancreas Cancer

Multidisciplinary Therapy of Pancreas Cancer:

recent advances and emerging paradigms

May 3-4, 2019

The University of Texas MD Anderson Cancer Center Frank E. Anderson Conference Hall 1515 Holcombe Boulevard Houston, TX 77030

goal

7KLVDFWLYLW\ZLOOSUHVHQWQHZWUHDWPHQWRSWLRQV WRSK\VLFLDQVDQGDIILOLDWHGKHDOWKSURIHVVLRQDOV IRUSDWLHQWVZLWKSDQFUHDWLFFDQFHU,QDGGLWLRQ PXOWLGLVFLSOLQDU\FDVHVWXGLHVZLOOEHSUHVHQWHG KLJKOLJKWLQJRSWLPDODSSURDFKHVWRFRPSOH[ VFHQDULRVLQWKLVGLVHDVH7KHORQJWHUPJRDORI WKHVHHIIRUWVLVWRLPSURYHWKHVXUYLYDOUDWHRI SDQFUHDWLFFDQFHUSDWLHQWVWKURXJKHYLGHQFH EDVHGDSSURDFKHV

educational objectives

After attending the conference, participants should be able to Implement genetic testing of patients and family members to screen for those who are at risk for developing pancreatic cancer and other cancers (knowledge, competence, performance, patient outcomes); E valuate, counsel and treat patients with pancreatic cancer at all stages of disease (locally advanced, resectable, borderline resectable, metastatic) (knowledge, competence, performance, patient outcomes); Provide a comprehensive understanding of innovative and emerging cancer therapies, inclusive of the side effects, to the cancer patient (knowledge, competence, performance, patient outcomes); and A pprise fellow clinicians and healthcare providers of emerging paradigms of the latest clinical trials and supportive care (knowledge, competence, performance, patient outcomes).

target audience

This conference should be of interest to Physicians, Advanced Practice Providers, Nurses, Researchers, Fellows and Trainees.

educational methods

Lectures

Case Study Question-and-Answer Session

evaluation

A course evaluation survey will provide participants with the opportunity to comment on the value of the program content to their practice decisions, performance improvement activities, or possible impact on patient health status. Participants will also have the opportunity to comment on any perceived commercial bias in the presentations as well as to identify future educational topics.

accreditation/

credit designation

The University of Texas MD Anderson Cancer Center is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide

continuing medical education for physicians.

The University of Texas MD Anderson Cancer Center designates this live activity for a maximum of 10.50 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

abim maintenance of

certification (moc)

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 10.50 Medical Knowledge MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to

submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

In order to receive MOC points, you will need to pass the post-test with a score of 70% or higher. You will be able to take the test as many times as you need to in order to pass.

Participant completion data will be shared with and transmitted to the ACCME on the participant's behalf.

ethics

The "Supportive Care" session has been designated by The University of Texas MD Anderson Cancer Center for .75 AMA PRA Category 1 CreditsTM in medical ethics and/or professional responsibility.

cme certificates and attendance verification certificates

Certificates awarding AMA PRA Category 1 CreditTM or certificates documenting attendance will be emailed when an individual completed the online CME Verification and Evaluation Questionnaire process after the conference.

A record of attendance (certificate) will be available online to other health care professionals for requesting credits in accordance with state nursing boards, specialty societies, or other professional associations.

md anderson program committee members

Robert A. Wolff, MD, Co-Chair Gastrointestinal Medical Oncology

Shubham Pant, MBBS Investigational Cancer Therapeutics

Matthew Katz, MD, Co-Chair Surgical Oncology

Anirban Maitra, MBBS Pathology, Anatomical

Gauri Varadhachary, MBBS, MD Gastrointestinal Medical Oncology

Joseph Herman, MD Radiation Oncology

Bettina Marble, MPA Sheikh Ahmed Center for Pancreatic Cancer Research

Felisha Estelle CME/Conference Management

Kelley Gilpin CME/Conference Management

Program Agenda

friday, may 3, 2019

3:00 pm

Registration

3:30

Welcome & Introductions

Robert A. Wolff, MD

3:45

Keynote

Christopher Lee Wolfgang, MD, MS, PhD

Translational Talks

4:30 5:00 5:30 6:00 6:30 6:35 - 8:30

Hereditary Pancreatic Cancer & High Risk Clinic Florencia McAllister, MD

MD Anderson Cyst Clinic Michael Kim, MD

Liquid Biopsies in Pancreatic Cancer Anirban Maitra, MBBS

Imaging Based Biomarkers Eugene Koay, MD, PhD

Closing Remarks and Adjourn Robert A. Wolff, MD

Welcome Reception

saturday, may 4, 2019

8:00 am

Registration and Continental Breakfast

8:30

Welcome & Introductions

8:45

Keynote

James Abbruzzese, MD

Multimodality Treatment

9:30 10:00 10:30

Preoperative Therapy for Resectable and Borderline Resectable PDAC Matthew Katz, MD

Adjuvant Therapy for Resected PDAC Michael Pishvaian, MD, PhD

Break

10:45

11:05

11:25 11:55 12:25 pm

Case Study: Preoperative Therapy for Resectable and Borderline Resectable PDAC Facilitators: Robert A. Wolff, MD, Joseph Herman, MD, David Fogelman, MD, Ching-Wei Tzang, MD and Eugene Koay, MD, PhD

Case Study: Adjuvant Therapy for PDAC Facilitators: Robert A. Wolff, MD, Joseph Herman, MD, Michael Pishvaian, MD, PhD, Grace Smith, MD and Michael Kim, MD

Management of Metastatic PDAC Michael Overman, MD

Role of the Gastroenterologist in PDAC Management Manoop Bhutani, MBBS

Lunch (provided)

Emerging Paradigms

1:30

Landscape of Phase 1 Studies

Shubham Pant, MBBS

2:00

Minimally Invasive Surgical Approaches

Naruhiko Ikoma, MD

2:30

Energy Ablative Technologies / IRE

Ching-Wei Tzeng, MD

3:00

Emerging Radiation Approaches in PDAC

Joseph Herman, MD

3:30

Break

3:40

Case Study:

Oligometastatic Disease and Locoregional Intervention

Facilitators: Milind Javle, MD and Chad Tang, MD

4:10

Case Study:

Sequencing of Therapies for LAPC

Facilitators: David Fogelman, MD and Sunil Krishnan, MD

Supportive Care (Ethics Credit)

4:40

Nutrition in Pancreatic Cancer

Maria Petzel, BS

5:05

Prioritizing the Patient Experience through Early Integration of

Supportive/ Palliative Care

Ishwaria M. Subbiah, MD

5:30

Adjourn

guest faculty

md anderson faculty

Manoop Bhutani, MBBS Gastroenterology, Hepatology & Nutrition

David Fogelman, MD Gastrointestinal Medical Oncology

Joseph Herman, MD Radiation Oncology

Naruhiko Ikoma, MD Surgical Oncology

Milind Javle, MD Gastrointestinal Medical Oncology

Matthew Katz, MD Surgical Oncology

Michael Kim, MD Surgical Oncology

Eugene Koay, MD, PhD Radiation Oncology

Sunil Krishnan, MD Radiation Oncology

Anirban Maitra, MBBS Pathology, Anatomical

Florencia McAllister, MD Clinical Cancer Prevention

Michael Overman, MD Gastrointestinal Medical Oncology

Shubham Pant, MBBS Investigational Cancer Therapeutics

Maria Petzel, BS Clinical Nutrition

Michael Pishvaian, MD, PhD Gastrointestinal Medical Oncology

Grace Smith, MD Radiation Oncology

Ishwaria M. Subbiah, MD Palliative Care

Chad Tang, MD Radiation Oncology

Ching-Wei Tzeng, MD Surgical Oncology

Robert A. Wolff, MD Gastrointestinal Medical Oncology

guest faculty

James Abbruzzese, MD Duke University School of Medicine Chief, Division of Medical Oncology Member of the Duke Cancer Institute Professor of Medicine Durham, North Carolina

Christopher Lee Wolfgang, MD, MS, PhD The Johns Hopkins University School of Medicine Director, Hepatobiliary and Pancreatic Surgery Professor of Surgery Baltimore, Maryland

registration information

On-site registration for the Multidisciplinary Therapy of Pancreas Cancer Conference opens at 3:00 p.m. on Friday, May 3, 2019. The opening session will begin at 3:30 p.m. on Friday, May 3, 2019 and the conference will adjourn at 5:30 p.m., Saturday, May 4, 2019.

Advanced registration is encouraged as space and materials are limited. Please see registration form for applicable fees.

The deadline for advanced registration is Friday, April 12, 2019.

There are three ways to register: 1. On-line at conferences 2. Fax to: 713-794-1724 3. Mail to: Department of CME/Conference Management Unit 1781 The University of Texas MD Anderson Cancer Center P.O. Box 301407 Houston, TX 77230-1407

We accept the following forms of payment: 1. Check (payable through U.S. banks only) 2. Money Order 3. Credit Cards (MasterCard, VISA, and American Express) 4. Cash (on-site registration only)

When registering online a confirmation letter (receipt) will be automatically emailed to the email address you list on the registration form. The confirmation letter will serve as your receipt. If you register by fax or mail, a confirmation letter will be emailed to you within ten working days of receipt of your fee.

The full conference registration fee includes the tuition, final program, continental breakfast, breaks, lunch and welcome reception.

refund/cancellation

policy

The registration fee, minus a $50 administrative handling fee, is refundable if a written request is received on or before April 12, 2019. No refunds will be

granted after that date. The request for a registration refund must include the tax identification number of the company or institution if registration was paid by a company or institution check.

The Department of CME/Conference Management reserves the right to cancel activities prior to the scheduled date, if low enrollment or other circumstances make it necessary. Each registrant will be notified by mail, e-mail, or at the phone or fax numbers given on the registration form.

In case of activity cancellation, liability of the Department of CME/Conference Management is limited to the registration fee. The Department of CME/Conference Management will refund the full registration fee. The Department of CME/ Conference Management reserves the right to limit the number of participants in a program and is not responsible for any expenses incurred by an individual whose registration is not confirmed and for whom space is not available.

For additional information, contact the Department of CME/Conference Management at 713-792-2223 or toll free at 866-849-5866.

special assistance

Contact the Department of CME/ Conference Management at 713-7922223 or toll free at 866-849-5866 if you have any special dietary or ADA accommodation needs.

accommodations

A block of rooms has been reserved for conference attendees at the Hilton Houston Plaza/Medical Center Hotel, 6633 Travis Street, Houston, Texas 77030.

Early hotel reservation is suggested.

The hotel phone number is 713-313-4000.

When you make reservations be sure to mention "MD Anderson Multidisciplinary Therapy of Pancreas Cancer Conference" or Group Code: "PCC" to be assured of receiving the special meeting rate of $129.00 single or double occupancy. Please add 17% Texas state and local taxes.

Room Reservation Website Link: Book your group rate for MD Anderson Multidisciplinary Therapy of Pancreas Cancer Conference

Reservations and deposits received after Thursday, April 11, 2019 will be confirmed if space is available and at current hotel published guest room rates.

ground transportation

Houston is served by two airports, George Bush Intercontinental (IAH) and William P. Hobby (HOU). The following forms of ground transportation are available to and from the airports to the Medical Center.

Uber and Lyft

Taxicabs: Yellow Cab 713-236-1111; and Fiesta Cab 713-225-2666.

Super Shuttle: For more information, call toll free at 800-258-3826, or on-line at

 ................
................

In order to avoid copyright disputes, this page is only a partial summary.

Google Online Preview   Download